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Abstract
Background: Dietary potassium supplementation in hypertensive rats is cardioprotective. This
protection includes a blood pressure independent reduction in the amount of damage caused by
cerebral ischemia. Therefore, we hypothesized that dietary potassium supplementation would
improve the outcome of ischemic stroke by improving cerebral vessel structure in normotensive
rats.
Methods: Wistar Kyoto (WKY) rats were fed a high (HK) or low potassium (LK) diet for six
weeks from six weeks of age. At the end of treatment, cerebral ischemia was induced by middle
cerebral artery (MCA) occlusion and the resultant infarct was quantified and expressed as a
percentage of the hemisphere infarcted (%HI). MCA structure was assessed in an additional group
of rats using a pressurized arteriograph.
Results: The cerebral infarct was significantly smaller in rats fed the HK diet, compared to rats fed
the LK diet (21 ± 5.4 vs 33.5 ± 4.8 %HI HK vs LK p < 0.05). Vessel structure was improved in WKY
rats fed the HK diet as indicated by an increase in the MCA lumen (298 ± 6.3 vs 276 ± 3.9 μm HK
vs LK p < 0.05) and outer diameters (322 ± 7.6 vs 305 ± 4.8 μm HK vs LK p < 0.05). Wall thickness
and area were unchanged, suggesting an outward euthrophic remodelling process. The HK diet had
no effect on body weight or telemetry blood pressure.
Conclusion: These studies are the first to show a beneficial effect of dietary potassium in rats with
normal blood pressure.
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Background
Epidemiological studies show that potassium intake cor-
relates inversely with the incidence of cerebrovascular
events [1-4]. It has been clear for some time that a high
potassium diet reduces the number of hemorrhagic
strokes in stroke prone spontaneously hypertensive rats
(SHRSP) [5,6] and reduces the risk of stroke in humans
[1-3]. We have also previously shown that administration
of spironolactone, a potassium sparing drug, reduces the
ischemic cerebral infarct size in SHRSP [7]. We have
recently shown that dietary potassium supplementation
also reduces the size of ischemic cerebral infarcts in
SHRSP and improves the structure of the MCA [8]. Inter-
estingly, dietary potassium supplementation did not alter
blood pressure in the SHRSP fed a normal sodium diet.
This presents the possibility that the effects of potassium
supplementation are blood pressure independent and
may also occur in normotensive rats.
Sixty to eighty percent of ischemic strokes can be attrib-
uted to hypertension [9]. However, there remains a signif-
icant population that suffers from an ischemic stroke
while their blood pressure is normal. It would therefore
seem prudent to assess if therapies that have been shown
to be beneficial in hypertensive rats can also reduce the
ischemic damage in rats with normal blood pressure.
Therefore we designed experiments to test the effects of a
HK diet in normotensive WKY rats.
Methods
Animals
Male WKY rats were purchased from Harlan (Indianapolis
IN). Rats were maintained on a 12-hour light dark cycle,
housed two per cage and allowed access to food and water
ad libitum. Rats were fed either a low potassium (LK) or a
high potassium (HK) chow containing 0.79% and 2.11%
potassium respectively (Zeigler Brothers: Gardners PA)
from 6 to 12 weeks of age. Both the HK and LK diets con-
tained 0.16% NaCl. These studies complied with the pro-
tocols for animal use outlined by the American
Physiological Society and were approved by the Institu-
tional Animal Care and Use Committee.
MCA occlusion
Rats were anesthetized with sodium pentobarbital (50
mg/kg IP) and body temperature was maintained at 37°C
during anaesthesia. The MCA was permanently occluded
using the intralumenal thread occlusion technique [10].
Briefly, the common carotid artery was exposed by a mid-
line incision and the branches of the external carotid
artery were cauterized. A 3-0 monofilament thread with a
rounded tip was introduced into the carotid artery and
advanced cranially into the internal carotid artery over a
distance of 19 mm, measured from the bifurcation of the
common carotid artery. The thread was left in place and
the rats were allowed to recover. Blood flow to the region
surrounding the MCA was measured using a laser Doppler
flow probe to confirm MCA occlusion. Post-occlusion (24
hours), the rats were anesthetized and decapitated and the
brains carefully removed. The area of the infarction was
quantified using 2,3,5-triphenyltetrazolium (TTC) stain-
ing as described previously. The area of the brain that
stained pink in response to TTC was deemed to be viable
tissue and the white area was classified as tissue damaged
by ischemia [7].
MCA structure
MCAs were isolated and placed in cold physiological salt
solution (PSS) (in mM: 141.9 NaCl, 4.7 KCl, 1.7 MgSO4,
0.5 EDTA, 2.8 CaCl2, 10.0 HEPES, 1.2 KH2PO4, and 5.0
glucose). The first branch-free segment of the MCA most
proximal to the Circle of Willis was mounted on two glass
micropipettes in a small vessel arteriograph (Living Sys-
tems Instrumentation, Burlington, VT). Vessels were
bathed with warm oxygenated PSS and the intralumenal
pressure was set at 75 mmHg before the vessels were
allowed to equilibrate for 30 minutes. Vessels that did not
hold pressure were discarded (vessels from 3 control rats
were discarded for this reason). For the analysis of vessel
structure, the vessels were bathed in calcium free PSS con-
taining 2 mM EGTA and the intralumenal pressure was
increased from 0 to 180 mmHg in 20 mmHg increments.
Videomicroscopy was used to measure lumen diameter,
external diameter and wall thickness at each pressure after
a 5-minute equilibration. The wall/lumen ratio, circum-
ferential wall stress, wall strain and distensibility were cal-
culated using the method of Baumbach and Hadju (13).
The vessel growth and remodelling indices were calcu-
lated for vessels at an intralumenal pressure of 80 mmHg
using the formula described by Heagerty et al [11]. The
elastic modulus (β-coefficient) was calculated from the
stress/strain curves for the individual vessels, these curves
were fitted to an exponential model (y = aeβx) where β is
the slope of the curve: the higher the β-coefficient the
stiffer the vessel.
Blood pressure and plasma electrolytes
Blood pressure was continuously monitored by telemetry
[12] (Data Sciences, Inc.; 20). Telemetry probes were
placed in the abdominal aorta of five-week old rats. Base-
line blood pressure was measured for 3 days before the
animals were placed on the specialized diets at six week of
age. Plasma sodium and potassium was measured using
the Synchron EL-ISE electrolyte system (Beckman Instru-
ments).
Chemicals
All general laboratory chemicals were purchased from
Sigma (St. Louis MO).Nutrition & Metabolism 2008, 5:3 http://www.nutritionandmetabolism.com/content/5/1/3
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Statistics
All results are represented as a mean ± standard error of
the mean. Cerebral vascular structure data and blood pres-
sures were analyzed by two-way repeated measures
ANOVA with a Bonferroni post-test. Cerebral infarct size,
plasma electrolytes, body weights and β-coefficients were
compared using Student's t-test. A p-value ≤ 0.05 was con-
sidered significant.
Results
Blood pressure, plasma electrolytes and body weights
Dietary potassium supplementation had no effect on the
mean arterial blood pressure in the WKY rats (Figure 1).
The rats from the two treatment groups had similar body
weights (274 ± 4.5 vs 265 ± 5.4 grams HK vs LK). The
plasma sodium levels were also similar between the two
groups (142 ± 1.8 vs 144 ± 1.7 HK vs LK), there was a
trend toward an increase in the plasma potassium levels in
the rats fed the HK diet (5.2 ± 0.2 vs 4.9 ± 0.2 HK vs LK p
= 0.25).
Cerebral infract size
Cerebral ischemia was induced by MCA occlusion. After
24 hours of ischemia the cerebral infarct was significantly
smaller in rats fed the HK diet, compared to rats fed the LK
diet (21 ± 5.4 vs 33.5 ± 4.8 %HI HK vs LK p < 0.05) (Figure
2). The percentage drop in blood flow, measured by laser
Doppler was the same in both groups of rats (data not
shown) indicating that the MCA was occluded to the same
extent in both groups and therefore the difference in inf-
arct size is due to differences in the ability of the vessels to
respond to ischemia and not a physical difference in the
way the MCA was occluded.
Passive vessel dynamics
The lumen and outer diameters of the MCA from the rats
fed the HK diet were significantly larger over the range of
intralumenal pressures than those from rats fed the LK
diet (Figure 3A and 3B). Assessment of the vessel wall
thickness and the wall to lumen ratio showed there were
no significant differences between the rats fed the HK and
Dietary potassium supplementation did not alter blood pressure in the WKY rats Figure 1
Dietary potassium supplementation did not alter blood pressure in the WKY rats. Blood pressure was measured by telemetry 
and the average day and night blood pressures are shown (n = 3 in each group).Nutrition & Metabolism 2008, 5:3 http://www.nutritionandmetabolism.com/content/5/1/3
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LK diets (Figure 4A and 4B), suggesting the MCA under-
went outward eutrophic remodelling in response to die-
tary potassium supplementation. Stress strain curves were
used to assess the compliance of the MCA, there was no
shift in the stress strain curve for the vessels from the rats
fed the HK diet compared to the rats fed the LK diet (Fig-
ure 5A), similarly, there was no change in the β-coefficient
(5.80 ± 1.15 vs 5.97 ± 0.61 HK vs LK). Dietary potassium
supplementation also had no effect on the distensibility
of the MCA (Figure 5B). The vessel remodelling and
growth indices were calculated for the HF rats at an intra-
lumenal pressure of 80 mmHg, the remodelling index was
110.83 indicating outward remodelling in the HK rats and
the growth index was -0.41, indicating no growth and a
small amount of atrophy.
Discussion
There are two novel findings in this study. First, we have
shown that dietary potassium supplementation reduces
the size of the ischemic cerebral infarct in normotensive
rats. We have also shown that the MCAs from the rats fed
the HK diet have larger lumen and outer diameters. Sev-
eral studies have shown that reducing the lumen and
outer diameters of the MCA reduces the vessels ability to
autoregulate [13], and dilate [14], both of these effects
may contribute to an increase in the amount of damage
caused by cerebral ischemia. Therefore, by increasing the
vessel diameters it is possible that the HK diet improved
cerebral vessel function and that this is responsible for the
reduction in the cerebral infarct size. To the best of our
Dietary potassium supplementation increases the inner (A)  and outer diameter (B) of the middle cerebral artery Figure 3
Dietary potassium supplementation increases the inner (A) 
and outer diameter (B) of the middle cerebral artery. Arter-
ies were mounted in a small vessel arteriograph and the inner 
and outer diameters of the vessels were measured over a 
range of intralumenal pressures (20–180 mmHg) under zero 
flow and calcium free conditions. Results were compared by 
a two way repeated measures ANOVA (p < 0.05) n = 5 for 
the HK group and 6 for the LK group).
Dietary potassium supplementation reduces the damage  caused by cerebral ischemia in WKY rats Figure 2
Dietary potassium supplementation reduces the damage 
caused by cerebral ischemia in WKY rats. Cerebral ischemia 
was induced by MCA occlusion using the intralumenal suture 
occlusion technique and the size of the ischemic infarct was 
measured twenty-four hours later. The upper panel shows 
representative brain slices from WKY rats fed the HK and 
LK diets. The light area is tissue damaged by ischemia and the 
dark area is viable tissue. The lower panel shows the cerebral 
infarct size expressed as a percentage of the hemisphere 
damaged by ischemia (n = 6 in both groups, p < 0.05).Nutrition & Metabolism 2008, 5:3 http://www.nutritionandmetabolism.com/content/5/1/3
Page 5 of 7
(page number not for citation purposes)
knowledge this is the first study to show a beneficial effect
of dietary potassium supplementation in a normotensive
rat.
In these studies the rats were fed the specialized diets for
six weeks beginning at six weeks of age, this time frame
was chosen to mimic the treatment regime used in our
previous studies of the effects of dietary potassium supple-
mentation in SHRSP [8]. In that study we observed that
dietary potassium supplementation reduced the ischemic
cerebral infarct size and improved cerebral vessel structure
in hypertensive rats. The results obtained in the current
study suggest that potassium supplementation has a sim-
ilar effect in normotensive rats. Interestingly, the pattern
of changes in vessel structure is not the same in the SHRSP
and WKY rats. In the SHRSP we observed no change in the
lumen diameter of the MCA but reduction in the wall
thickness and wall/lumen ratio [8]. This suggests that in
the hypertensive rats the HK diet is preventing vessel
hypertrophy or hyperplasia. This was not the case in the
WKY rats, here the changes in vessel structure with dietary
potassium supplementation appear to reflect an outward
euthrophic remodeling process, or a increase in the vessel
size without a change in the wall thickness, this is sup-
ported by the calculations of the remodeling and growth
indices. Why the hypertensive rats and normotensive rats
respond differently to the HK diet remains unclear. It is
Dietary potassium supplementation has no effect on the ves- sel compliance as indicated by the stress strain curve (A) or  the vessel distensibilty (B) Figure 5
Dietary potassium supplementation has no effect on the ves-
sel compliance as indicated by the stress strain curve (A) or 
the vessel distensibilty (B). Arteries were mounted in a small 
vessel arteriograph and vessel structure was assessed as 
described previously. These results were used to calculate 
the circumferencial wall stress, wall strain and distensibility. n 
= 5 for the HK group and 6 for the LK group.
Dietary potassium supplementation has no effect on the wall  thickness (A) or the wall/lumen ratio in the WYK rats Figure 4
Dietary potassium supplementation has no effect on the wall 
thickness (A) or the wall/lumen ratio in the WYK rats. Arter-
ies were mounted in a small vessel arteriograph and the wall 
thickness and lumen diameters of the vessels were measured 
over a range of intralumenal pressures (20–180 mmHg) 
under zero flow and calcium free conditions and the wall/
lumen ratio was calculated. Results were compared by a two 
way repeated measures ANOVA (NS) n = 5 for the HK 
group and 6 for the LK group.Nutrition & Metabolism 2008, 5:3 http://www.nutritionandmetabolism.com/content/5/1/3
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possible that the difference in blood pressure between the
two strains is responsible for the different responses. Also,
in the SHRSP the HK diet caused a significant increase in
the plasma potassium concentrations, while there was a
trend towards an increase in the WKY rats it did not reach
statistical significance. This raises the possibility that there
are differences in the potassium handling between the
two strains and that may be responsible for the difference
in the effect.
The mechanism for the effect of the HK diet on vascular
structure in the WKY rats remains unclear. Our previous
studies using SHRSP showed that the mRNA levels of var-
ious growth factor receptors and collagens were reduced
by the HK diet [8]. Because we do not observe a change in
vessel wall thickness in the WKY rats it seems unlikely that
the HK diet is preventing growth factor stimulated smooth
muscle hypertrophy in the WKY rats. Similarly we
observed a reduction in vessel compliance and a reduc-
tion in collagen mRNA levels in the SHRSP fed the HK diet
[8]. Other studies have also suggested that dietary potas-
sium supplementation improves vessel compliance in
patients with essential hypertension [15]. In the current
study we did not observe a difference in compliance or
vessel stiffness, therefore it is unlikely that this is the
mechanism for the protective effect of potassium.
It should be noted that the effects of dietary potassium
supplementation on the outcome of cerebral ischemia
may not be due solely to the changes in lumen diameter.
A small increase in potassium concentration causes a
reduction in reactive oxygen species (ROS) generation
[16]. ROS generation has also been implicated in the
pathogenesis of acute ischemic stroke [17], therefore a
reduction in ROS generation after the induction of
ischemia could be responsible for the beneficial effects of
potassium on the outcome of ischemia. Similarly, the pro-
inflammatory cytokine, interleukin 1 beta (IL-1β) levels
increase rapidly in the brain in response to an ischemic
insult [18]. Interestingly, we have shown that dietary
potassium supplementation in SHRSP causes a dramatic
reduction in the plasma concentration of IL-1β [19], pre-
senting the possibility that this too has an effect on the
outcome of ischemia in the normotensive rat.
Conclusion
In conclusion, we have shown very clear evidence that die-
tary potassium supplementation reduces the amount of
damage caused by cerebral ischemia and increases the
MCA lumen and outer diameter in WKY rats. To the best
of our knowledge this is the first study to assess the effec-
tiveness of this very simple treatment and cost effective
treatment in a normotensive rat.
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